Internal Medicine · Park Ridge, IL
NPI
1689976649
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1875 Dempster St Ste 180
Park Ridge, IL, 60068
Phone (630) 366-6681
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
738 services
Medicare patients, 2024
141
Average age 75
Drug cost, 2024
$2.3M
23,171 prescriptions
Company payments, 2025
$57.82
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chool Liyanapatabendi was code 99232 (hospital e&m - subsequent), 176 times for 33 patients. In total Chool Liyanapatabendi billed 738 services in 17 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 176 | 33 | $64.78 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 148 | 46 | $97.28 | $14K |
| 99308 SNF E&M | Office | 148 | 66 | $52.16 | $7,720 |
| 99223 Hospital E&M - Initial | Facility | 85 | 57 | $141.91 | $12K |
| 99239 Hospital Discharge Management | Facility | 71 | 47 | $93.32 | $6,626 |
| 99214 Office E&M - Established | Office | 18 | 11 | $95.36 | $1,716 |
By year: 2022 $156K for 1,959 services; 2023 $231K for 2,812 services; 2024 $61K for 738 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chool Liyanapatabendi prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,342 prescriptions and refills. In total Chool Liyanapatabendi wrote 23,171 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,342 | 1,404 | 233 | $26K |
| Eliquis Apixaban | 1,018 | 1,020 | 112 | $305K |
| Levothyroxine Sodium Generic | 649 | 701 | 119 | $10K |
| Gabapentin Generic | 600 | 616 | 107 | $12K |
| Amlodipine Besylate Generic | 537 | 565 | 114 | $5,009 |
| Potassium Chloride Generic | 503 | 510 | 97 | $18K |
| Metoprolol Tartrate Generic | 465 | 481 | 87 | $5,118 |
| Quetiapine Fumarate Generic | 452 | 460 | 85 | $9,765 |
| Mirtazapine Generic | 438 | 446 | 78 | $14K |
| Donepezil Hcl Generic | 416 | 422 | 64 | $6,467 |
| Omeprazole Generic | 411 | 423 | 76 | $6,282 |
| Tamsulosin Hcl Generic | 402 | 418 | 72 | $8,272 |
| Furosemide Generic | 371 | 394 | 88 | $3,233 |
| Sertraline Hcl Generic | 362 | 366 | 70 | $5,178 |
| Pantoprazole Sodium Generic | 349 | 383 | 76 | $5,743 |
Brand drugs: 3,868 claims; generic drugs: 19,248 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chool Liyanapatabendi $57.82 ($57.82 in general payments such as food, travel and fees) from 2 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $36.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.